Ascendis Pharma A (ASND) Other Working Capital Changes (2012 - 2026)

Ascendis Pharma A has disclosed Other Working Capital Changes across 15 years of filings, most recently posting $45.2 million for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $45.2 million, up 877.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.2 million (up 322.79% YoY), and the FY2025 annual result was $39.2 million, up 29.92% from the prior year.
• Other Working Capital Changes came in at $45.2 million for Q1 2026 at Ascendis Pharma A, up from -$5.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $45.2 million in Q1 2026 to a low of -$10.9 million in Q1 2023.
• The 5-year median for Other Working Capital Changes is $774354.7 (2022), against an average of $5.9 million.
• Across the five-year window, Other Working Capital Changes sank 321.85% in 2023 and soared 877.57% in 2026, its largest moves.
• Ascendis Pharma A's Other Working Capital Changes stood at $2.5 million in 2022, then tumbled by 321.85% to -$5.6 million in 2023, then surged by 200.58% to $5.6 million in 2024, then sank by 189.81% to -$5.0 million in 2025, then jumped by 997.78% to $45.2 million in 2026.
• The last three Other Working Capital Changes figures came in at $45.2 million (Q1 2026), -$5.0 million (Q4 2025), and $34.4 million (Q3 2025), per Business Quant data.